According to Amedisys's latest financial reports the company has $0.10 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.12 B | 211.91% |
2022-12-31 | $40.54 M | -5.05% |
2021-12-31 | $42.69 M | -47.81% |
2020-12-31 | $81.8 M | 170.05% |
2019-12-31 | $30.29 M | 49.76% |
2018-12-31 | $20.22 M | -76.58% |
2017-12-31 | $86.36 M | 186% |
2016-12-31 | $30.19 M | 9.8% |
2015-12-31 | $27.5 M | 242.41% |
2014-12-31 | $8.03 M | -53.58% |
2013-12-31 | $17.3 M | 18.96% |
2012-12-31 | $14.54 M | -69.7% |
2011-12-31 | $48 M | -60.09% |
2010-12-31 | $0.12 B | 248.83% |
2009-12-31 | $34.48 M | 1111.28% |
2008-12-31 | $2.84 M | -94.93% |
2007-12-31 | $56.19 M | -33.28% |
2006-12-31 | $84.22 M | 388.78% |
2005-12-31 | $17.23 M | -80.79% |
2004-12-31 | $89.67 M | 201.15% |
2003-12-31 | $29.77 M | 512.61% |
2002-12-31 | $4.86 M | 38.29% |
2001-12-31 | $3.51 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
LHC Group LHCG | $17.91 M | -83.45% | ๐บ๐ธ USA |
National Healthcare
NHC | $0.22 B | 106.61% | ๐บ๐ธ USA |
Chemed CHE | $0.31 B | 189.51% | ๐บ๐ธ USA |